Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday, 1 February 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
George Grigoiadis
et al
. published in
Annals of Hematology
.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment